Q1 FY27: Net Sales up 26.32%, PAT rises 23.89% QoQ

Revenue Growth 20pctEbitda Margin ExpansionExceptional ItemResults View source PDF Explain this filing

MOLDTKPAC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.1%Reaction day

₹731.95

prior close

₹728.35

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-7.5% vs market

Packaging peers, median of 62sector+0.7%-6.8% vs sector

On the reaction day the stock moved 7.5 pts less than Nifty Microcap 250 and 6.8 pts less than its Packaging peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.2

10m

-4.2

15m

-2.9

30m

-2.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.1+1.3-7.5+0.7-6.8

Next day

-10.2+0.0-10.3-0.3-9.9

-10.4+0.5-10.9-0.3-10.1

-7.8-0.1-7.8-0.6-7.2

-8.3+1.0-9.3-0.3-8.1

-7.5+2.4-9.9-0.2-7.3

-6.8+4.1-10.9+0.4-7.2

15d

-7.1+5.1-12.2+6.3-13.4

-4.2+5.8-10.0+3.8-8.0

-11.6+4.5-16.1+1.9-13.5

-59.6-2.4-57.2-2.2-57.4

UpDownMarket · Nifty Microcap 250Sector · Packaging peers, median of 62Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mold-Tek Packaging Q1 FY27 results: Net Sales up 26.32% QoQ and 24.90% YoY to Rs 300.45 cr. PAT grew 23.89% QoQ and 14.15% YoY to Rs 25.57 cr. EBITDA up 17.31% QoQ at Rs 56.43 cr. EBITDA per kg hit historical high of Rs 46.68. Volume grew 5.82% QoQ. Pharma packs volume up 38.75%, Food and FMCG up 26.20%, Paints up 10.82%. Hyderabad unit consolidation lifted capacity utilisation to 75%.

Likely market impact

Strong all-round performance with record EBITDA per kg and broad-based volume growth across segments. Capacity expansion in pharma and FMCG signals positive momentum ahead.